🕵️ RANI Therapeutics Holdings, Inc. ($RANI)
SEC insider & ownership activity, last 12 months · CIK 1856725 · every row links its SEC filing
Insider sell value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), May 11, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $1.3M (3 lots) · 3 sellers, value withheld pending verification (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| South CONE Investments Limited Partnership | 0 | – | 2 | $15.7M | Oct 21, 2025 |
| Mir A. Imran | 2 | $1.3M | 0 | – | Jul 21, 2026 |
| Imran Talat | 1 | $25K | 1 | value withheld pending verification | Jul 17, 2026 |
| Javadi Alireza | 0 | – | 1 | $301 | Mar 27, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Mir A. Imran | 22.1% | 13D | Oct 23, 2025 | filing ↗ | |
| InCube LABS, L.L.C. | 18.7% | 13D | Oct 23, 2025 | filing ↗ | |
| Raymond Debbane | 10.0% | 13G | Oct 23, 2025 | filing ↗ | |
| Srinivas Akkaraju | 9.9% | 13D | May 26, 2026 | filing ↗ | |
| AWM Investment Company, Inc. | 9.9% | 13G | Feb 13, 2026 | filing ↗ | |
| RA Capital Management, L.P. | 9.9% | Class A | 13G | Aug 14, 2026 | filing ↗ |
| Peter Kolchinsky | 9.9% | Class A | 13G | Aug 14, 2026 | filing ↗ |
| Rajeev Shah | 9.9% | Class A | 13G | Aug 14, 2026 | filing ↗ |
| RA Capital Healthcare Fund, L.P. | 9.9% | Class A | 13G | Aug 14, 2026 | filing ↗ |
| Invus Public Equities, L.P. | 8.8% | 13G | Oct 23, 2025 | filing ↗ | |
| Invus Public Equities Advisors, LLC | 8.8% | 13G | Oct 23, 2025 | filing ↗ | |
| Invus Global Management, LLC | 8.8% | 13G | Oct 23, 2025 | filing ↗ | |
| Siren, L.L.C. | 8.8% | 13G | Oct 23, 2025 | filing ↗ | |
| Samsara BioCapital, L.P. | 5.0% | 13D | May 26, 2026 | filing ↗ | |
| Samsara BioCapital GP, LLC | 5.0% | 13D | May 26, 2026 | filing ↗ | |
| Samsara Opportunity Fund, L.P. | 5.0% | 13D | May 26, 2026 | filing ↗ | |
| Samsara Opportunity Fund GP, LLC | 5.0% | 13D | May 26, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 28, 2026 | filing ↗ |
| Other events (8.01) | May 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 26, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Delisting notice (3.01) | May 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Agreement terminated (1.02) | Dec 31, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Dec 31, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 31, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 31, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 22, 2025 | filing ↗ |
| Other events (8.01) | Oct 22, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 16, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 16, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 16, 2025 | filing ↗ |